Loading
Life sciences · Journal article
International Journal of Molecular Sciences · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Male reproductive disorders are increasingly linked to metabolic diseases, but mechanistic research remains predominantly focused on the testis. The seminal microenvironment, shaped by epididymal and accessory-gland secretions, contains metabolites, lipids, ions, cytokines, extracellular vesicles, and microbial products, and may act as a metabolically responsive post-testicular interface that continues to influence sperm after spermatogenesis. Obesity, insulin resistance, dyslipidemia, and chronic inflammation can remodel this environment by disrupting secretory activity, redox homeostasis, immune signaling, and microbial ecology. These changes may converge on oxidative and inflammatory pathways, promoting membrane lipid peroxidation, mitochondrial dysfunction, impaired motility and capacitation, oxidative DNA base lesions, DNA fragmentation, and potentially epigenetic alterations. Mouse studies separately report obesity-associated epididymal vesicle remodeling and RNA-dependent changes in embryonic gene expression. In this Review, we examine the regulation and metabolic remodeling of the seminal microenvironment, how these changes may translate systemic metabolic stress into sperm injury, and emerging interventions including metabolic correction, antioxidant strategies, and microbiome-targeted approaches. Overall, current evidence remains largely observational and cross-sectional, with additional technical limitations in low-biomass seminal microbiome studies. Longitudinal and mechanistic studies are therefore needed to determine whether the seminal microenvironment is a causal mediator of metabolic infertility and a clinically tractable target for mechanism-guided preconception care.